New research is being presented at HFSA 2014, the 18th Annual Scientific Meeting of the Heart Failure Society of America, from September 14 to 17 in Las Vegas.
Meeting Highlights
Iron & Inflammation in Pulmonary Hypertension
DSE Screening Accurately Predicted post-Transplant Adverse Events
Arrhythmias Common After LVAD Implantation; Did Not increase Mortality Risk
Shared End-of-Life Decisions in Patients With ICDs
Improving Care With Heart Failure Patient Perspectives
Worsening Renal Function in Acute Heart Failure
Left Ventricular End-Diastolic Pressure, STEMI, & PCI
News From HFSA 2014
Withdrawal of HF Meds Can Be Safe After Cardiotoxic Cancer Chemotherapy
Pump Up: Ablation Reverses Poor LV Function in Atrial Fib
MIBG Imaging Aids Risk Assessment for Congestive HF Patients
Elevated CVP After LVAD Implantation Increased GI Bleeding Risk
Trials Bolster Hopes New K-Binding Agents Will Prevent, Treat HF-Related Hyperkalemia
William T. Abraham, MD, Discusses PARACHUTE III Results (Video)
Super Bowl Sunday Shares in the Holiday HF Hazard
As Used, Spironolactone Doesn’t Cut 30-Day HF Readmissions
Poor Sleep, Poor HF Outcomes: Routinely Test Sleep Quality?
More From HFSA 2014
